| Jun'18 | Jun'17 | |||||
|---|---|---|---|---|---|---|
Revenues | ||||||
54 | 82 | |||||
Cost of revenues: | ||||||
Products and services | ||||||
27 | 29 | |||||
Inventory impairment | ||||||
99 | 0 | |||||
Gross profit (loss) | ||||||
-72 | 53 | |||||
Research and development expenses | ||||||
471 | 615 | |||||
Sales and marketing expenses | ||||||
240 | 236 | |||||
General and administrative expenses | ||||||
337 | 550 | |||||
Operating loss | ||||||
-1,120 | -1,348 | |||||
Profit (loss) from changes in fair value of warrants issued to investors | ||||||
-38 | 2,137 | |||||
Financial income in respect of deposits and exchange rate differences, net | ||||||
23 | 20 | |||||
Financial expenses in respect of bank commissions | ||||||
3 | 8 | |||||
Financial income (loss), net | ||||||
-18 | 2,149 | |||||
Profit (loss) before taxes on income | ||||||
-1,138 | 801 | |||||
Taxes benefit (Taxes on income) | ||||||
11 | 13 | |||||
Profit (loss) and total comprehensive profit (loss) for the period | ||||||
-1,149 | 788 | |||||
Basic earnings (loss) per ordinary share | ||||||
-0.06 | 0.06 | |||||
Diluted earnings (loss) per ordinary share | ||||||
-0.06 | 0.02 | |||||
Weighted average number of ordinary shares outstanding used to compute (in thousands) | ||||||
Basic earnings (loss) per ordinary share | ||||||
19,179 | 13,767 | |||||
Diluted earnings (loss) per ordinary share | ||||||
19,179 | 15,128 | |||||